Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Analysis of Over 140,000 European Descendants Identifies Genetically Predicted Blood Protein Biomarkers Associated with Prostate Cancer Risk

23 Jul 2019

Abstract excerpt

Abstract Several blood protein biomarkers have been associated with prostate cancer risk. However, most studies assessed only a small number of biomarkers and/or included a small sample size. To identify novel protein biomarkers of prostate cancer risk, we studied 79,194 cases and 61,112 controls of European ancestry, included in the PRACTICAL/ELLIPSE consortia, using genetic instruments of protein quantitative...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Associations and Epidemiology
Share to Prostate Cancer Diagnosis and Treatment
Share to Prostate Cancer Treatment and Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31337649
DOI: 10.1158/0008-5472.can-18-3997

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Analysis of Over 140,000 European Descendants Identifies Genetically Predicted Blood Protein Biomarkers Associated with Prostate Cancer RiskPMID 31337649Read ↗

Identification of blood protein biomarkers associated with prostate cancer risk using genetic prediction models: analysis of over 140,000 subjectsSemantic proximity Read ↗

Associations between genetically predicted concentrations of plasma proteins and the risk of prostate cancer.Semantic proximity Read ↗

Proteome-wide association study of prostate cancer risk across populations.Semantic proximity Read ↗

Identifying proteomic risk factors for overall, aggressive and early onset prostate cancer using Mendelian randomization and tumor spatial transcriptomicsSemantic proximity Read ↗

Causal associations between plasma proteins and prostate cancer: a Proteome-Wide Mendelian RandomizationSemantic proximity Read ↗

Transcriptome-Wide Association Study Identified Novel Blood Tissue Gene Biomarkers for Prostate Cancer Risk.Semantic proximity Read ↗

Multi-omics biomarker pipeline reveals elevated levels of protein-glutamine gamma-glutamyltransferase 4 in seminal plasma of prostate cancer patientsSemantic proximity Read ↗

Identifying proteomic risk factors for overall, aggressive, and early onset prostate cancer using Mendelian Randomisation and tumour spatial transcriptomics.Semantic proximity Read ↗

A Minimal Plasma Proteome-Based Biomarker Panel for Accurate Prostate Cancer DiagnosisSemantic proximity Read ↗

Proteome-wide Mendelian randomization identifies causal plasma proteins in prostate cancer development.Semantic proximity Read ↗

Biomarkers in Prostate Cancer EpidemiologySemantic proximity Read ↗

Identification of novel serological tumor markers for human prostate cancer using integrative transcriptome and proteome analysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.